publicações selecionadas
-
artigo académico
- Chromene-based compounds as drug candidates for renal and bladder cancer therapy – A systematic review. Bioorganic Chemistry. 2024
- Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma. Cancer Chemotherapy and Pharmacology. 2024
- Biopsychosocial Factors That Influence the Purpose in Life among Working Adults and Retirees. International Journal of Environmental Research and Public Health. 2023
- Repurposing some of the Well-known Non-steroid Anti-inflammatoryDrugs (NSAIDs) for Cancer Treatment. Current Topics in Medicinal Chemistry. 2023
-
documento
- Epigenetic modulation of kdm4c as a therapeutic strategy for triple-negative breast cancer 2025
- Design de novos inibidores da KDM4C para o tratamento do cancro da mama triplo negativo 2025
- KDM4C epigenetic therapy for triple-negative breast cancer 2024
- Design of new epigenetic inhibitors for the treatment of triple negative breast cancer 2024
- Therapeutic epigenetic KDM4C remodeling for the treatment of triple negative breast cancer 2024
- Virtual screening of potential KDM4C inhibitors for the treatment of triple negative breast cancer 2023
- Development of virtual screening protocols for the design of novel KDM4C inhibitors for the treatment of triple negative breast cancer 2023
- Optimization of specialized virtual screening protocols for the design of new KDM4C inhibitor molecules for the treatment of triple negative breast cancer 2023
- Otimização de protocolos especializados de virtual screening para o design de novas moléculas inibidoras da KDM4C para o tratamento do cancro da mama triplo negativo 2023
- Chitinase 3-like-1 identified in large extracellular vesicles from human macrophages: a promising therapeutic drug target for pancreatic cancer (Best Poster Award in the session I of EVs in Cancer) 2023
- Darifenacin as novel chemosensitizer in pancreatic cancer 2023
- Efeito sensibilizador da darifenacina a agentes citotóxicos no cancro pancreático: estudo in silico e em linhas celulares 2022
- Targeting Chitinase-like-1 (CHI3L1) as a therapeutic target for pancreatic cancer 2021
- Identification of Chitinase 3-like 1 as a therapeutic target for pancreatic cancer in large extracellular vesicles from human macrophages 2021
- Targeting chitinase 3-like 1 in pancreatic cancer: in silico identification of inhibitors from a DrugBank database and confirmation of growth inhibition effect in cell lines 2021
- Virtual screening of known drugs in search of inhibitors of CHI3L1 for the treatment of pancreatic cancer 2021
- Evaluation of the potential of propolis from Alentejo as biopesticide 2021
- Assessment of job satisfaction for designing career management interventions 2007
-
livro
-
teses